VR Logo

Artemis Global Life Sciences Ltd. download report


Healthcare | Drugs & Pharma

Artemis Global Life Sciences Ltd. Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

Financial Year Full AR Chairman's
Speech
Director's
Report
Management
Discussion
Corporate
Governance
Auditor's
Report
Notes to
Accounts
2019 Artemis Global Life Sciences Ltd. Annual Report Artemis Global Life Sciences Ltd. director's report Artemis Global Life Sciences Ltd. management discussion Artemis Global Life Sciences Ltd. corporate governance Artemis Global Life Sciences Ltd. auditor's report Artemis Global Life Sciences Ltd. account notes
2018 Artemis Global Life Sciences Ltd. Annual Report Artemis Global Life Sciences Ltd. chairman speech Artemis Global Life Sciences Ltd. director's report Artemis Global Life Sciences Ltd. management discussion Artemis Global Life Sciences Ltd. corporate governance Artemis Global Life Sciences Ltd. auditor's report Artemis Global Life Sciences Ltd. account notes
2017 Artemis Global Life Sciences Ltd. Annual Report Artemis Global Life Sciences Ltd. chairman speech Artemis Global Life Sciences Ltd. director's report Artemis Global Life Sciences Ltd. management discussion Artemis Global Life Sciences Ltd. corporate governance Artemis Global Life Sciences Ltd. auditor's report Artemis Global Life Sciences Ltd. account notes
2016 Artemis Global Life Sciences Ltd. Annual Report Artemis Global Life Sciences Ltd. chairman speech Artemis Global Life Sciences Ltd. director's report Artemis Global Life Sciences Ltd. management discussion Artemis Global Life Sciences Ltd. corporate governance Artemis Global Life Sciences Ltd. auditor's report Artemis Global Life Sciences Ltd. account notes

About The Company

Business: Manufacture of basic iron and steel

Incorporated: 2011

Chairman: Onkar S Kanwar

Managing Director: Devlina Chakravarty

Group: Raunaq Singh

Listing: BSE: 540616, NSE: AGLSL

Country: India

Headquarters: New Delhi, Delhi

Website: www.aglsl.in

Key Facts

Market cap: ₹327.30 Cr

Revenue (TTM): ₹555.79 Cr

Earnings (TTM): ₹21.11 Cr

Cash: ₹12.38 Cr

Total Debt: ₹114.18 Cr

Promoters' ownership: 69.82%

Liquidity:

52 Week range: ₹-- - --

Face value: ₹2.00

Shares outstanding: 6,61,88,500

9 Years Aggregate:

  • CFO: ₹164.15 Cr
  • EBITDA: ₹173.66 Cr
  • Net Profit: ₹73.80 Cr

Stock Performance

Time Period Artemis Global Life Sciences S&P BSE Sensex* S&P BSE Healthcare*
YTD-22.92-8.99-17.55
1 month-6.43-3.40-3.85
3 months-1.59-8.50-11.97
1 Year-32.540.89-15.43
3 Years--10.4118.79
5 Years--11.439.09
10 Years--11.7712.12
As on 23-Oct-2019 *As on 30-Jun-2022
Year Artemis Global Life Sciences S&P BSE Sensex S&P BSE Healthcare
2018-44.895.87-5.89